| The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier TP Buzhdygan, BJ DeOre, A Baldwin-Leclair, TA Bullock, HM McGary, ... Neurobiology of disease 146, 105131, 2020 | 467 | 2020 |
| HIV infects astrocytes in vivo and egresses from the brain to the periphery V Lutgen, SD Narasipura, HJ Barbian, M Richards, J Wallace, ... PLoS pathogens 16 (6), e1008381, 2020 | 124 | 2020 |
| Selection of an efficient AAV vector for robust CNS transgene expression KS Hanlon, JC Meltzer, T Buzhdygan, MJ Cheng, M Sena-Esteves, ... Molecular Therapy-Methods & Clinical Development 15, 320-332, 2019 | 114 | 2019 |
| The fibroblast growth factor 14· voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3) AS Shavkunov, NC Wildburger, MN Nenov, TF James, TP Buzhdygan, ... Journal of Biological Chemistry 288 (27), 19370-19385, 2013 | 100 | 2013 |
| CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability WCJ Hsu, F Scala, MN Nenov, NC Wildburger, H Elferink, AK Singh, ... The FASEB Journal 30 (6), 2171, 2016 | 41 | 2016 |
| Atg5 Supports Rickettsia australis Infection in Macrophages In Vitro and In Vivo J Bechelli, L Vergara, C Smalley, TP Buzhdygan, S Bender, W Zhang, ... Infection and immunity 87 (1), 10.1128/iai. 00651-18, 2019 | 36 | 2019 |
| Neuropsychological, neurovirological and neuroimmune aspects of abnormal GABAergic transmission in HIV infection T Buzhdygan, J Lisinicchia, V Patel, K Johnson, V Neugebauer, ... Journal of Neuroimmune Pharmacology 11, 279-293, 2016 | 34 | 2016 |
| The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties TP Buzhdygan, CR Rodrigues, HM McGary, JA Khan, AM Andrews, ... Journal of Neuroinflammation 18, 1-15, 2021 | 12 | 2021 |
| ErbB3 is a critical regulator of cytoskeletal dynamics in brain microvascular endothelial cells: implications for vascular remodeling and blood brain barrier modulation L Wu, MR Islam, J Lee, H Takase, S Guo, AM Andrews, TP Buzhdygan, ... Journal of Cerebral Blood Flow & Metabolism 41 (9), 2242-2255, 2021 | 8 | 2021 |
| The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic TP Buzhdygan, BJ DeOre, A Baldwin-Leclair, TA Bullock, HM McGary, ... Vitro, 2020 | 6 | 2020 |
| Extracellular microvesicles released from brain endothelial cells are detected in animal models of HIV-1 signifying unresolved inflammation SH Ramirez, TP Buzhdygan, JF Hale, L Cheng, G Li, ... Journal of Neuroimmune Pharmacology 16, 785-795, 2021 | 5 | 2021 |
| The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier. bioRxiv Prepr Serv Biol [Internet]. 2020 … TP Buzhdygan, BJ DeOre, A Baldwin-Leclair, H McGary, R Razmpour, ... Disponible en: Disponible en: http://www. ncbi. nlm. nih. gov/pubmed/32587958, 0 | 3 | |
| Anomalies of GABAergic system associated with HIV-1 infection T Buzhdygan | | 2015 |
